# Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

> **NCT01258374** · — · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 15 (actual)

## Conditions studied

- Integrase Inhibitors, HIV; HIV PROTEASE INHIB

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Darunavir

## Key facts

- **NCT ID:** NCT01258374
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01258374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01258374, "Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01258374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*